<DOC>
	<DOC>NCT00387725</DOC>
	<brief_summary>Study to evaluate the safety of an investigational meningitis vaccine and the immune response to it in adolescents</brief_summary>
	<brief_title>Study Evaluating Safety &amp; Immunogenicity of rLP2086 Vaccine in Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria Aged 8 to 14 years at the time of enrollment. Healthy male or female subjects Negative urine pregnancy test for female subjects Exclusion Criteria Prior vaccination with a meningococcal B vaccine Prior meningococcal disease</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Adolescent</keyword>
	<keyword>Meningococcal</keyword>
	<keyword>Safety</keyword>
</DOC>